PITTSBURGH — Mylan on Friday announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the U.S. Food and Drug Administration for its phenytoin chewable tablets USP in the ...

Mylan is one of a group of drugmakers that have joined the global effort to supply doses of generic hydroxychloroquine, an antimalarial touted as a possible COVID-19 therapy, to ongoing clinical ...

Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Norethindrone and Ethinyl Estradiol Tablets (Chewable) 0.8 mg/0.025 mg and Ferrous Fumarate Tablets, 75 mg (Chewable), which is the generic ...

HERTFORDSHIRE, England and PITTSBURGH, March 19, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced its continued commitment to do its part in support of public health needs amidst the ...

Hyderabad, July 27 (IANS) Mylan Pharmaceutical, a subsidiary of Mylan N.V., on Thursday announced the launch of Velpatasvir 100 mg/Sofosbuvir 400 mg tablets under the brand name MyHep All in India.

Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust ...

Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Felbamate Tablets USP, 400 mg and 600 mg, which is the generic version of Meda Pharms' Felbatol® Tablets. Mylan received final ...

Aurobindo has acquired clorazepate dipotassium tablets from Mylan, a Viatris company. The drug was acquired in dosage strengths of 3.75 mg, 7.5 mg and 15 mg. Aurobindo began to market, distribute, and ...

Mylan Inc. has begun to market Cabergoline Tablets USP, 0.5 mg to treat hyperprolactinemic disorders. The Southpointe-based Mylan (Nasdaq: MYL) said it received final approval from the Food and Drug ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Mylan said in its statement hours after the news conference ...

PITTSBURGH, April 21 /PRNewswire-FirstCall/ -- Mylan Inc. NYSE: MYL today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and ...